NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
Publication
, Journal Article
Kumar, SK; Callander, NS; Hillengass, J; Liedtke, M; Baljevic, M; Campagnaro, E; Castillo, JJ; Chandler, JC; Cornell, RF; Costello, C; Godby, K ...
Published in: J Natl Compr Canc Netw
October 1, 2019
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
October 1, 2019
Volume
17
Issue
10
Start / End Page
1154 / 1165
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Multiple Myeloma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, S. K., Callander, N. S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., … Kumar, R. (2019). NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw, 17(10), 1154–1165. https://doi.org/10.6004/jnccn.2019.0049
Kumar, Shaji K., Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, et al. “NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.” J Natl Compr Canc Netw 17, no. 10 (October 1, 2019): 1154–65. https://doi.org/10.6004/jnccn.2019.0049.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, et al. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154–65.
Kumar, Shaji K., et al. “NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.” J Natl Compr Canc Netw, vol. 17, no. 10, Oct. 2019, pp. 1154–65. Pubmed, doi:10.6004/jnccn.2019.0049.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, Kumar R. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154–1165.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
October 1, 2019
Volume
17
Issue
10
Start / End Page
1154 / 1165
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Multiple Myeloma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis